Discontinuation report MODERIBA

Last updated on 2018-08-30 History
Report ID 29907
Drug Identification Number 02436396
Brand name MODERIBA
Common or Proper name MODERIBA TABLETS 200MG
Company Name ABBVIE CORPORATION
Active Ingredient(s) RIBAVIRIN
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 168 tabs/bottle
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-09-30
Actual discontinuation date 2018-07-02
Remaining supply date 2018-09-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Last lot available on market expired on Sept. 30th, 2018. Per AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.
Company comments This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-08-30 French Compare
v8 2018-08-30 English Compare
v7 2017-11-30 French Compare
v6 2017-11-30 English Compare
v5 2017-11-23 English Compare
v4 2017-11-23 English Compare
v3 2017-11-21 English Compare
v2 2017-11-21 English Compare
v1 2017-11-21 English Compare